Moderna has enrolled 4,536 study subjects in trials for their COVID-19 vaccine so far. The trial began on July 27 and the company intends to enroll 30,000 study subjects. According to Moderna, the company is "on track to complete enrollment in September," subjects must wait 28 days between receiving their first and second shot. However, this means that a shot will not be ready by Election Day, as was the original goal of the Trump administration. Yourway is the premium courier needed for extensive trials, as we have two decades of experience and a robust global footprint. We deliver faster turnaround times, flexibility to choose a range of transport options, and all the requisite quality and regulatory compliance for high-value therapeutics.